These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Pharmacological effects of neurotensin, substance P and tuftsin]. Herman ZS Postepy Biochem; 1985; 31(3-4):487-508. PubMed ID: 2430270 [No Abstract] [Full Text] [Related]
4. Central cardiovascular effects of vasotocin, oxytocin and vasopressin in conscious rats. Feuerstein G; Zerbe RL; Faden AI J Pharmacol Exp Ther; 1984 Feb; 228(2):348-53. PubMed ID: 6694114 [TBL] [Abstract][Full Text] [Related]
5. [Effect of neurotensin and substance P on the active state of the gastric smooth muscles]. Shmigol' AV; Dem'ianenko VS Fiziol Zh SSSR Im I M Sechenova; 1989 Jun; 75(6):829-36. PubMed ID: 2478399 [TBL] [Abstract][Full Text] [Related]
6. Effects of oxytocin and vasopressin in the central and in the autonomic nervous system. Interactions with other presumptive neurotransmitters. Dreifuss JJ; Kiraly M; Dolivo M; Wuarin JP; Raggenbass M Regul Pept Suppl; 1985; 4():165-71. PubMed ID: 2865771 [No Abstract] [Full Text] [Related]
7. [Pharmacologic properties of hydrazine derivatives of methylxanthines]. Krupińska J Folia Med Cracov; 1970; 12(2):251-83. PubMed ID: 5433429 [No Abstract] [Full Text] [Related]
8. [The action of vasopressin and oxytocin on the nervous structures of Periplaneta americana L]. Schulz H Arch Int Pharmacodyn Ther; 1970 Jul; 186(1):108-19. PubMed ID: 5473170 [No Abstract] [Full Text] [Related]
9. [Pharmacological studies on isolated smooth muscle organs of the gold hamster]. Daum A; Lembeck F Arzneimittelforschung; 1969 Sep; 19(9):1603-8. PubMed ID: 4310203 [No Abstract] [Full Text] [Related]
10. [Neurotensin, a multi-action peptide hormone]. St-Pierre S; Quirion R; Regoli D; Gervais A; Lavigne F; Poirier A; Jolicoeur F; Barbeau A; Rioux F Union Med Can; 1980 Oct; 109(10):1447-55. PubMed ID: 7466969 [No Abstract] [Full Text] [Related]
11. [The prostaglandins and their biologic effects]. Gajdos A Presse Med (1893); 1968 Mar; 76(11):513-6. PubMed ID: 5646254 [No Abstract] [Full Text] [Related]
12. Distribution of the neurophysin-vasopressin system in the mammalian hypothalamus. Zimmerman EA Isr J Med Sci; 1976 Sep; 12(9):994-1003. PubMed ID: 826505 [No Abstract] [Full Text] [Related]
13. Innervation of the muscularis mucosa in the canine stomach and colon. Angel F; Schmalz PF; Morgan KG; Go VL; Szurszewski JH Scand J Gastroenterol Suppl; 1982; 71():71-5. PubMed ID: 6176013 [TBL] [Abstract][Full Text] [Related]
14. Peripheral and central nervous actions of substance P antagonists. Rosell S; Folkers K Adv Biochem Psychopharmacol; 1982; 33():471-6. PubMed ID: 6181662 [TBL] [Abstract][Full Text] [Related]
15. Physiological and clinical significance of hypothalamic and extrahypothalamic brain peptides. Guillemin R Triangle; 1976; 15(1):1-7. PubMed ID: 822545 [No Abstract] [Full Text] [Related]
16. Metabolic activities of human neurophysins. Trygstad O; Foss I; Sletten K Ann N Y Acad Sci; 1975 Feb; 248():304-16. PubMed ID: 1054547 [No Abstract] [Full Text] [Related]
17. [The effect of neurotensin on the cardiovascular system]. Osadchiĭ OE; Pokrovskiĭ VM Usp Fiziol Nauk; 1998; 29(2):39-54. PubMed ID: 9659683 [TBL] [Abstract][Full Text] [Related]
18. [Substance P in the central mechanism of the rabbit feeding response evoked by stimulation of the lateral hypothalamus]. Zilov VG; Rogacheva SK; Ivanova LI; Patyshakuliev AP Biull Eksp Biol Med; 1984 Jan; 97(1):3-5. PubMed ID: 6198008 [TBL] [Abstract][Full Text] [Related]
19. The effects of neuropeptides: substance P, somatostatin, neurotensin and enkephalins on the myoelectric activity of the small intestine. Thor P; Laskiewicz J; Konturek J; Konturek SJ Mater Med Pol; 1987; 19(1):47-51. PubMed ID: 2452328 [No Abstract] [Full Text] [Related]
20. Pharmacodynamic and toxicological studies of Kalanchoe integra stem. Varma RK; Garg BD; Ahmad A Mater Med Pol; 1986; 18(4):207-10. PubMed ID: 3613680 [No Abstract] [Full Text] [Related] [Next] [New Search]